FLNA (Filana Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades

Filana Therapeutics, Inc. Common Stock (FLNA) is a publicly traded the market company. As of May 21, 2026, FLNA trades at $1.23 with a market cap of $57.49M and a P/E ratio of 0.00. FLNA moved +4.58% today. Year to date, FLNA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.16 to $2.27. Rallies surfaces FLNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded FLNA stock?

Rallies tracks politician and congressional stock disclosures for FLNA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

FLNA Key Metrics

Key financial metrics for FLNA
MetricValue
Price$1.23
Market Cap$57.49M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$2.27
52-Week Low$1.16
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest FLNA News

FLNA Analyst Consensus

FLNA analyst coverage data. Average price target: $0.00.

Common questions about FLNA

Which politicians traded FLNA stock?
Rallies tracks politician and congressional stock disclosures for FLNA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in FLNA?
Yes. Rallies tracks politician and congressional stock disclosures for FLNA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is FLNA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FLNA. It does not provide personalized investment advice.
FLNA

FLNA